refractory leukemia
Showing 1 - 18 of 18
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)
Recruiting
- Refractory Leukemia
- CALGE-VEN- RIC-MBF
-
Shanghai, Shanghai, China
- +2 more
May 22, 2023
Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded
Not yet recruiting
- Refractory Leukemia
- +4 more
- STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
- Dendritic Cell Vaccine
-
Miami, FloridaUniversity of Miami
Jan 23, 2023
T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)
Recruiting
- T-lymphoblastic Lymphoma
- +5 more
- BCL2 Inhibitor plus IM2 regimen
-
Shanghai, Shanghai, ChinaShanghai General hospital,Shanghai Jiao Tong University School o
Jan 10, 2023
Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)
Recruiting
- Recurrent Leukemia
- Refractory Leukemia
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Acute Leukemia, Recurrent Leukemia, Refractory Leukemia Trial in Columbus (Best Practice, Bright White Light Therapy, Survey
Recruiting
- Acute Leukemia
- +2 more
- Best Practice
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 14, 2022
Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed Leukemia Trial in
Not yet recruiting
- Lymphoblastic Leukemia, Acute, Childhood
- +3 more
- Olverembatinib, APG-2575, Dexamethasone
-
Hefei, Anhui, China
- +3 more
Aug 8, 2022
Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- venetoclax combining chidamide and azacitidine (VCA)
-
Xiamen, Fujian, ChinaBing Xu
Aug 1, 2022
Solving Riddles Through Sequencing
Recruiting
- Leukemia
- +5 more
- Next Generation Sequencing
-
Munich, GermanyMLL Munich Leukemia Laboratory
Jan 19, 2022
Relapsed or Refractory Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
-
Cona, Ferrara, Italy
- +26 more
Jan 3, 2022
Relapse Leukemia, Refractory Leukemia Trial in Shenzhen (Allogeneic CD19 CAR-T cells)
Recruiting
- Relapse Leukemia
- Refractory Leukemia
- Allogeneic CD19 CAR-T cells
-
Shenzhen, Guangdong, ChinaLi Yu
Dec 7, 2021
Immunotherapy, Refractory Leukemia, Relapsed Adult AML Trial in Suzhou (Visilizumab)
Recruiting
- Immunotherapy
- +3 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 2, 2021
Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (CAR
Recruiting
- Lymphoblastic Leukemia, Acute, Childhood
- +6 more
- CAR T-cell therapy
-
Singapore, SingaporeAllen Yeoh Eng Juh
Sep 7, 2021
Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Leukemia Trial in Chengdu (Modified anti-CD19 CAR T cells)
Active, not recruiting
- Refractory B-Cell Non-Hodgkin Lymphoma
- Refractory Leukemia
- Modified anti-CD19 CAR T cells
-
Chengdu, Sichuan, ChinaSichuan University
Mar 17, 2021
Advanced Lymphoma, Refractory Lymphoma, Refractory Leukemia Trial in Vienna (Next generation functional drug screening,
Recruiting
- Advanced Lymphoma
- +4 more
- Next generation functional drug screening
- Comprehensive genomic profiling
-
Vienna, AustriaMedical University of Vienna
Jul 10, 2020
Stem Cell Transplant Complications, Relapse Leukemia, Refractory Leukemia Trial in Beijing (Decitabine, mBU/CY and ATG, mBU/CY)
Recruiting
- Stem Cell Transplant Complications
- +2 more
- Decitabine
- +2 more
-
Beijing, Beijing, ChinaPeking University Institute of Hematology,Beijing
May 27, 2019
Refractory Leukemia, Acute Myelogenous Leukemia Trial in Worldwide (Panobinostat/LBH589)
Completed
- Refractory Leukemia
- Acute Myelogenous Leukemia
-
Chicago, Illinois
- +39 more
Jan 8, 2017